THE FACT ABOUT NVS-CECR2-1 THAT NO ONE IS SUGGESTING

), allows to clarify why KIF15 is able to facilitate resistance to Eg5 inhibitors in vivo. MT gliding run by the two of such mitotic motors was arrested only after they were being separately inhibited, lending support to your proposal that a combination drug therapy targeting these motors may be a workable system for overcoming chemotherapeutic res